Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A First in human clinical study of OraPro-COVID-19

Trial Profile

A First in human clinical study of OraPro-COVID-19

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 30 Sep 2020

At a glance

  • Drugs COVID-19 vaccine Stabilitech Biopharma (Primary)
  • Indications COVID 2019 infections
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 30 Sep 2020 According to an iosBio media release, the company expect to initiate this trial in Q1 2021.
    • 24 Mar 2020 New trial record
    • 19 Mar 2020 According to a Stabilitech Biopharma media release, the company plans to initiate this study within weeks.

Trial Overview

Purpose

This trial will evaluate OraPro-COVID-19.

Diseases Treated

Indication Qualifiers Patient Segments
COVID 2019 infections treatment -

Subjects

  • Subject Type patients
  • Sex male & female

Trial Details

Organisations

  • Affiliations iosBio

Trial Dates

  • Initiation Dates

    Planned : 01 Jan 2021

Other Details

  • Design multicentre; prospective
  • Phase of Trial Phase I
  • Location Europe; USA
  • Focus Adverse reactions; First in man

Interventions

Drugs Route Formulation
COVID-19 vaccine Stabilitech BiopharmaPrimary Drug Oral
-

Trial History

Event Date Event Type Comment
30 Sep 2020 Other trial event According to an iosBio media release, the company expect to initiate this trial in Q1 2021. Updated 01 Oct 2020
24 Mar 2020 New trial record New trial record Updated 24 Mar 2020
19 Mar 2020 Other trial event According to a Stabilitech Biopharma media release, the company plans to initiate this study within weeks. Updated 24 Mar 2020

References

  1. Stabilitech Biopharma. Stabilitech's COVID-19 Vaccine Intended to Be Delivered in a Disruptive Thermally Stable Oral Capsule. Media-Rel 2020;.

    Media Release
  2. Stabilitech Biopharma, iosBio. Stabilitech Biopharma announces name change to iosBio. Media-Rel 2020;.

    Media Release
Back to top